Zdrowie i gospodarka · 25/11/2016
FDA Releases Revised Draft Guidance for Cyclobenzaprine Hydrochloride Bioequivalence Studies
The Food and Drug Administration has released a revised draft guidance for the pharmaceutical industry on the bioequivalence of generic cyclobenzaprine hydrochloride extended release capsules, providing specific recommendations for supporting abbreviated new drug applications.